Literature DB >> 28682938

Improving Patient Selection for Refractory Out of Hospital Cardiac Arrest Treated with Extracorporeal Life Support.

Tahar Chouihed1,2,3, Antoine Kimmoun4,2,5,6, Adrien Lauvray1, Francois-Xavier Laithier4, Deborah Jaeger1, Simon Lemoine5, Juan Pablo Maureira5, Lionel Nace1, Kevin Duarte3,5,6, Stéphane Albizzati7, Nicolas Girerd2,3,5,6, Bruno Levy4,2,5,6.   

Abstract

BACKGROUND: Despite recent management improvement, including Extracorporeal Life Support (ECLS), refractory out of hospital cardiac arrest (ROHCA) survival remains dramatically low.
METHODS: We assessed an innovative strategy (Out of hoSpital Cardiac ARrest-ExtraCorporeal Life Support-"OSCAR-ECLS") to optimize access to ECLS of ROHCA patients and reduce the delay between recognition and ECLS implantation.
METHODS: This study, conducted in a tertiary teaching hospital, compared the survival and delay times of ROHCA patients treated by ECLS before and after OSCAR-ECLS implementation. This procedure included an early recognition of ROHCA 10 min after initiation of advanced cardiopulmonary resuscitation; the optimization of patient selection and reduction in time from collapse to ECLS initiation.
RESULTS: Fourteen patients before and 32 patients after OSCAR-ECLS implementation were identified between 2013 and 2016. Time to ECLS initiation was 99 (90-107) min before OSCAR-ECLS vs. 80 (65-94) min during the OSCAR-ECLS period (P = 0.0007), mostly due to a reduction in time spent on site: 48 (40.0-54.0) min vs. 24 (20.0-28.0) min (P = 0.0001). Survival at hospital discharge was 7% (1/14) before OSCAR-ECLS and 25% (8/32) during the OSCAR-ECLS period (P = 0.20). Only one patient survived with a Glasgow Pittsburgh Cerebral Performance Category (CPC) score = 1 before the OSCAR-ECLS procedure while during the OSCAR-ECLS procedure, eight patients (25%) survived, six with a CPC score = 1, one with a CPC score = 2, and one with a CPC score = 3.
CONCLUSIONS: The use of a new paradigm of ROHCA dramatically shortened the time to ECLS initiation by reducing the time spent on site by more than 20 min. Survival improved from 7% to 25% after implementation of OSCAR-ECLS.

Entities:  

Mesh:

Year:  2018        PMID: 28682938     DOI: 10.1097/SHK.0000000000000941

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  2 in total

1.  Methylene Blue Reduces Fluid Loading and Norepinephrine Requirements for Post-Resuscitation Syndrome in a Pig Model of Refractory Cardiac Arrest Resuscitated with Veno-Arterial ECMO.

Authors:  Benjamin Pequignot; Mickael Lescroart; Sophie Orlowski; Nathan Reynette; Bana Martini; Eliane Albuisson; Héloise Pina; N'Guyen Tran; Daniel Grandmougin; Bruno Levy
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

2.  Resuscitative Endovascular Balloon Occlusion of the Aorta in Experimental Cardiopulmonary Resuscitation: Aortic Occlusion Level Matters.

Authors:  Emanuel M Dogan; Linus Beskow; Fredrik Calais; Tal M Hörer; Birger Axelsson; Kristofer F Nilsson
Journal:  Shock       Date:  2019-07       Impact factor: 3.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.